Author Description

The past two decades have brought many changes to the diagnosis and treatment of cancer in general, and especially to those for hematologic malignancies. Research has resulted in deeper understanding and insight into the molecular mechanisms and pathophysiology of this unique group of cancers. The recent advances in cancer therapeutics have lead to the development and availability of an increasing array of novel chemotherapeutic agents and biological therapies. The availability of these effective new agents and treatment regimens has nonetheless greatly increased the complexity of selecting appropriate therapeutic modalities in individual patients. This has resulted in the issuance of updated evidence-based clinical practice guidelines to optimize the diagnosis and management of patients with hematologic malignancies. This concise yet comprehensive mini-handbook volume provides oncologists and other healthcare professionals with essential, evidence-based guidance on the diagnosis and treatment of all major hematologic malignancies, including malignant lymphoma, multiple myeloma and acute leukemia.SERIES OVERVIEWThe Oxford American Mini-Handbooks are a series of concisely-formatted adaptations of Oxford American Handbooks. They provide a focused and succinct summary on a specific area of a particular discipline, serving as a portable, easily accessible resource at the point of care. These smaller volumes capture the essentials of assessment and treatment in an exceptionally affordable and more clinically relevant format. Featuring useful tables and bulleted lists, these books provide a readily available resource to specialists and general practitioners alike.